NCT00078390 - Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

September 28, 2006

Study Completion Date

October 26, 2006

Conditions

Non Small Cell Lung CancerLung CancerStage IIIA Non Small Cell Lung CancerStage IIIB Non Small Cell Lung Cancer

Interventions

DRUG

S-3304

S-3304 will be administered at the tolerable dose BID along with chemo-irradiation

OTHER

Chemo-irradiation

Standard of care chemo-irradiation

Trial Locations (5)

Lombardi Cancer Center, Washington D.C.

The Cleveland Clinic, Cleveland

University of Kansas Cancer Center, Kansas City

Scripps Cancer Institute, La Jolla

VA Medical Center-East Orange (study available to veterans only), East Orange